Medical & Biological Laboratories financials at a glance
Year | Year | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rev. | Revenue |
|
4.93B | 5.02B | 5.14B | 5.36B | 5.89B | 6.09B | 6.25B | 6.56B | 6.92B | 7.17B | 7.61B | 8.06B | 7.35B | 7.07B | 8.18B | 9.23B | 0.00M | 0.00M |
GM % | Gross Margin % |
|
63.42% | 56.39% | 62.74% | 58.31% | 62.09% | 64.12% | 64.34% | 64.20% | 60.66% | 55.94% | 55.26% | 55.81% | 57.54% | 56.63% | 55.19% | 58.55% | 0.00% | 0.00% |
OM | Operating Margin |
|
4.01% | -1.38% | 4.46% | 0.64% | 1.75% | 7.92% | 6.34% | 5.81% | 3.44% | -7.24% | -11.04% | -4.57% | 1.09% | 1.71% | 6.07% | 14.45% | 0.00% | 0.00% |
EPS | Earnings Per Share |
|
0.00 | 0.00 | ||||||||||||||||
Div. | Dividends |
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sha. | Shares |
|
3.47m | 6.94m | 3.47m | 3.47m | 3.47m | 3.43m | 3.43m | 3.43m | 3.43m | 5.17m | 5.17m | 5.17m | 5.17m | 5.17m | 5.17m | 5.17m | 0m | 0m |
OCF | Operating Cash Flow |
|
110.11M | 626.16M | 614.16M | 559.38M | 737.49M | 629.44M | 599.00M | 670.00M | 351.00M | 333.00M | -492.00M | 125.00M | 833.00M | 275.00M | 822.00M | 2.12B | 0.00M | 0.00M |
FCF | Free Cash Flow |
|
-52.38M | 215.10M | 525.76M | 464.86M | 629.23M | 427.00M | 232.00M | 405.00M | -243.00M | -79.00M | -833.00M | -1658.00M | 564.00M | -18.00M | 301.00M | 1.72B | 0.00M | 0.00M |
FCFS | Free Cash Flow Per Share |
|
-30.75 | 54.73 | 137.41 | 127.76 | 162.71 | 94.91 | 84.83 | 116.61 | -28.16 | -16.05 | -179.27 | -327.21 | 106.17 | -64.98 | 82.00 | 340.95 | 0.00 | 0.00 |